159 related articles for article (PubMed ID: 31543462)
61. The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.
Mao P; Wortham AM; Enns CA; Zhang AS
J Biol Chem; 2019 Feb; 294(6):2060-2073. PubMed ID: 30559294
[TBL] [Abstract][Full Text] [Related]
62. Hepcidin: A key regulator of iron.
Saneela S; Iqbal R; Raza A; Qamar MF
J Pak Med Assoc; 2019 Aug; 69(8):1170-1175. PubMed ID: 31431773
[TBL] [Abstract][Full Text] [Related]
63. Cell surface serine protease matriptase-2 suppresses fetuin-A/AHSG-mediated induction of hepcidin.
Stirnberg M; Maurer E; Arenz K; Babler A; Jahnen-Dechent W; Gütschow M
Biol Chem; 2015 Jan; 396(1):81-93. PubMed ID: 25205713
[TBL] [Abstract][Full Text] [Related]
64. Matriptase-2, a regulatory protease of iron homeostasis: possible substrates, cleavage sites and inhibitors.
Stirnberg M; Gütschow M
Curr Pharm Des; 2013; 19(6):1052-61. PubMed ID: 23016685
[TBL] [Abstract][Full Text] [Related]
65. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.
Ganz T; Nemeth E; Rivella S; Goldberg P; Dibble AR; McCaleb ML; Guo S; Monia BP; Barrett TD
Adv Ther; 2023 Apr; 40(4):1317-1333. PubMed ID: 36690839
[TBL] [Abstract][Full Text] [Related]
66. 3-Amidinophenylalanine-derived matriptase inhibitors can modulate hepcidin production in vitro.
Pászti-Gere E; Szombath G; Gütschow M; Steinmetzer T; Székács A
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):511-520. PubMed ID: 31659405
[TBL] [Abstract][Full Text] [Related]
67. Inflammation regulates TMPRSS6 expression via STAT5.
Meynard D; Sun CC; Wu Q; Chen W; Chen S; Nelson CN; Waters MJ; Babitt JL; Lin HY
PLoS One; 2013; 8(12):e82127. PubMed ID: 24376517
[TBL] [Abstract][Full Text] [Related]
68. The role of TMPRSS6 gene variants in iron-related hematological parameters in Turkish patients with iron deficiency anemia.
Batar B; Bavunoglu I; Hacioglu Y; Cengiz M; Mutlu T; Yavuzer S; Yavuzer H; Cuhadar Ercelebi D; Erhan D; Unal S; Tunckale A; Guven M
Gene; 2018 Oct; 673():201-205. PubMed ID: 29928945
[TBL] [Abstract][Full Text] [Related]
69. Hemojuvelin: the hepcidin story continues.
Malyszko J
Kidney Blood Press Res; 2009; 32(2):71-6. PubMed ID: 19287179
[TBL] [Abstract][Full Text] [Related]
70. Molecular analysis of homeostatic iron regulator, transmembrane protease serine-6, and BTB domain-containing protein-9 variants and iron parameters in blood donors.
Fawzy MS; Fakhr-Eldeen A; Abu AlSel BT; Toraih EA
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33367529
[TBL] [Abstract][Full Text] [Related]
71. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity.
Guillem F; Kannengiesser C; Oudin C; Lenoir A; Matak P; Donadieu J; Isidor B; Méchinaud F; Aguilar-Martinez P; Beaumont C; Vaulont S; Grandchamp B; Nicolas G
Hum Mutat; 2012 Sep; 33(9):1388-96. PubMed ID: 22581667
[TBL] [Abstract][Full Text] [Related]
72. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
[TBL] [Abstract][Full Text] [Related]
73. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
Silvestri L; Guillem F; Pagani A; Nai A; Oudin C; Silva M; Toutain F; Kannengiesser C; Beaumont C; Camaschella C; Grandchamp B
Blood; 2009 May; 113(22):5605-8. PubMed ID: 19357398
[TBL] [Abstract][Full Text] [Related]
74. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
[TBL] [Abstract][Full Text] [Related]
75. A strong anti-inflammatory signature revealed by liver transcription profiling of Tmprss6-/- mice.
Riba M; Rausa M; Sorosina M; Cittaro D; Garcia Manteiga JM; Nai A; Pagani A; Martinelli-Boneschi F; Stupka E; Camaschella C; Silvestri L
PLoS One; 2013; 8(7):e69694. PubMed ID: 23922777
[TBL] [Abstract][Full Text] [Related]
76. Immunoassay for human serum hemojuvelin.
Brasse-Lagnel C; Poli M; Lesueur C; Grandchamp B; Lavoinne A; Beaumont C; Bekri S
Haematologica; 2010 Dec; 95(12):2031-7. PubMed ID: 20713458
[TBL] [Abstract][Full Text] [Related]
77. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.
D'Alessio F; Hentze MW; Muckenthaler MU
J Hepatol; 2012 Nov; 57(5):1052-60. PubMed ID: 22728873
[TBL] [Abstract][Full Text] [Related]
78. The role of TMPRSS6/matriptase-2 in iron regulation and anemia.
Wang CY; Meynard D; Lin HY
Front Pharmacol; 2014; 5():114. PubMed ID: 24966834
[TBL] [Abstract][Full Text] [Related]
79. Identification of the first low-molecular-weight inhibitors of matriptase-2.
Sisay MT; Steinmetzer T; Stirnberg M; Maurer E; Hammami M; Bajorath J; Gütschow M
J Med Chem; 2010 Aug; 53(15):5523-35. PubMed ID: 20684597
[TBL] [Abstract][Full Text] [Related]
80. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.
Wake M; Palin A; Belot A; Berger M; Lorgouilloux M; Bichon M; Papworth J; Bayliss L; Grimshaw B; Rynkiewicz N; Paterson J; Poindron A; Spearing E; Carter E; Hudson R; Campbell M; Petzer V; Besson-Fournier C; Latour C; Largounez A; Gourbeyre O; Fay A; Coppin H; Roth MP; Theurl I; Germaschewski V; Meynard D
Blood Adv; 2024 Apr; 8(8):1898-1907. PubMed ID: 38241484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
